Patents by Inventor Yixuan LI

Yixuan LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939307
    Abstract: Disclosed are a benzyl piperazine compound, a preparation method there for and an application thereof in an antivirus. The benzyl piperazine compound has a structure represented by the following general formula(I). It is proven by experiments that the benzyl piperazine compound not only has significant antiviral activity, but also has the advantages of low cytotoxicity, a high selectivity index and soon.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 26, 2024
    Assignee: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Xinbei Jiang, Yixuan Wang, Jianrui Li, Jiali Tan
  • Publication number: 20220301768
    Abstract: Provided are a method for manufacturing a molded composite inductor, and a molded composite inductor. The method includes: putting a plurality of conductors apart from each other into a mold, and extending two ends of each of the plurality of conductors out of the mold; filling the mold with magnetic powder such that the magnetic powder covers the plurality of conductors, and applying pressure to the magnetic powder such that the magnetic powder forms a magnetic body and is integrated with the plurality of conductors to form an inductor module.
    Type: Application
    Filed: August 14, 2020
    Publication date: September 22, 2022
    Applicants: Shenzhen Boke New Material Co., Ltd., Huizhou Poco Magnetic Co., Ltd., Huizhou Boke Industry Co., Ltd.
    Inventors: Guohua Wang, Xiongzhi Guo, Zhuoquan Wu, Yunfan Zhang, Qiang Xiao, Bohui Wang, Zhihang Jiang, Yang Chen, Kai He, Yunkai Cao, Yixuan Li
  • Publication number: 20220293315
    Abstract: The present application relates to an internally embedded copper plate-type soft magnetic powder core inductor, a preparation method therefor, and a use thereof. The internally embedded copper plate-type soft magnetic powder core inductor comprises a copper plate, a surface of the copper plate is covered with a soft magnetic material, and an interfacing area of the soft magnetic material and the copper plate includes an insulating resin material.
    Type: Application
    Filed: June 30, 2020
    Publication date: September 15, 2022
    Applicants: Shenzhen Boke New Material Co., Ltd., Huizhou Poco Magnetic Co., Ltd., Huizhou Boke Industry Co., Ltd.
    Inventors: Yunfan Zhang, Xiongzhi Guo, Qiang Xiao, Guohua Wang, Yixuan Li, Kai He, Xuemin Chen, Jialin Ruan, Yunkai Cao, Zhengping Li
  • Publication number: 20220275192
    Abstract: Disclosed in the present invention are a polyvinyl alcohol (PVA)-based degradable plastic, a preparation method therefor and application thereof, and a recycling method therefor. The preparation method comprises the following steps: a PVA solution is subjected to a chemical grafting reaction under an acidic condition under the action of a modifier; there are a phenyl group, an aldehyde group, and at least one group capable of forming a hydrogen bond with PVA in a structural formula of the modifier. The polyvinyl alcohol-based degradable plastic provided in the present invention has the advantages of being high in transparency, high in mechanical strength, not affected by environmental humidity, easy to degrade, good in thermal stability and good in biocompatibility, and has the advantages of recyclability, low costs, easy large-scale preparation and the like.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 1, 2022
    Inventors: Junqi Sun, Xu Fang, Yixuan Li
  • Publication number: 20210228689
    Abstract: A use of lactoferrin in the preparation of a food or drug, the food or drug being used for activating a VDR signaling pathway, which is used for the treatment of bone disease, bone disease comprising: osteoporosis, bone damage, loss of bone calcium, incomplete bone development and bone abnormalities. The present invention further comprises screening for drugs that are used to promote osteoblast proliferation and differentiation by using an active state of the VDR signaling pathway.
    Type: Application
    Filed: May 31, 2018
    Publication date: July 29, 2021
    Inventors: Huiyuan GUO, Yixuan LI, Hao ZHANG, Liang ZHAO